IMNM - Immunome  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMNM is currently covered by 2 analysts with an average price target of $22.6. This is a potential upside of $13.27 (142.23%) from yesterday's end of day stock price of $9.33.

Immunome 's activity chart (see below) currently has 3 price targets and 8 ratings on display. The stock rating distribution of IMNM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60% with an average time for these price targets to be met of 109.25 days.

Highest price target for IMNM is $33, Lowest price target is $33, average price target is $22.6.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 25-Oct-2024. First documented stock forecast 20-Aug-2021.

Best performing analysts who are covering IMNM - Immunome :

Matthew Barcus David Nierengarten Brian Cheng Geulah Livshits

Currently out of the existing stock ratings of IMNM, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$33

$23.09 (233.00%)

$33

27 days ago
(25-Oct-2024)

2/5 (40%)

$20.89 (172.50%)

14

Buy

$8

$-1.91 (-19.27%)

$9

1 years 8 months 4 days ago
(17-Mar-2023)

3/3 (100%)

$2.31 (40.60%)

398

Buy

$33

$8.26 (33.39%)

$35

2 years 10 months 10 days ago
(11-Jan-2022)

0/2 (0%)

$21.36 (183.51%)

Buy

$21

$12.65 (151.50%)

3 years 3 months 1 days ago
(20-Aug-2021)

1/1 (100%)

$8.5 (68.00%)

25

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMNM (Immunome ) average time for price targets to be met?

On average it took 109.25 days on average for the stock forecasts to be realized with a an average price target met ratio 60

Which analyst has the current highest performing score on IMNM (Immunome ) with a proven track record?

MATTHEW BARCUS

Which analyst has the current lower performing score on IMNM (Immunome ) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on IMNM (Immunome )?

Matthew Barcus has 3 price targets and 3 ratings on IMNM

Which analyst is the currently most bullish on IMNM (Immunome )?

David Nierengarten with highest potential upside - $23.09

Which analyst is the currently most reserved on IMNM (Immunome )?

Matthew Barcus with lowest potential downside - -$1.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?